Cameroon Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Cameroon Pharmaceuticals and Healthcare Report Q3 2013 May 8th 2013, 00:00 BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon is unlikely to be of significant interest to multinational pharmaceutical firms. The country’s shortcomings include poor public health provision and rampant corruption. Consequently we project that the full potential of the pharmaceutical sector will only be seen if major improvements are made to Cameroon’s economy and government contributions to healthcare. Headline Expenditure Projections ? Pharmaceuticals: XAF134.81bn (US$260mn) in 2012 to XAF153.17bn (US$310mn) in 2013; +13.6% in local currency terms and +20.3% in US dollar terms. Forecast upgraded from Q213, following reassessment of historic numbers. ? Healthcare: … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=94956. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cameroon-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions